Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2017 14:41 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Provides Update on Public Market Trading Status

GAITHERSBURG, Md., March 06, 2017 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB:AURX) (“Nuo” or the “Company”), announced today that the Depository Trust Company (“DTC”) has approved the...
December 18, 2015 17:15 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Announces Execution of Third Limited Consent With Deerfield Management Through January 7, 2016

GAITHERSBURG, Md., Dec. 18, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQX:NUOT), today announced that the Company has entered into a third limited consent with Deerfield Management, L.P....
December 14, 2015 08:30 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Announces Appointment of Chief Restructuring Officer

GAITHERSBURG, Md., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQX:NUOT), today announced that it has engaged Winter Harbor LLC to assist the company in its financial restructuring...
December 07, 2015 08:30 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Announces Execution of Second Limited Consent With Deerfield Management Through December 17, 2015

GAITHERSBURG, Md., Dec. 7, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced that on December 4, 2015, it entered into a limited consent...
November 12, 2015 20:24 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Announces Execution of Limited Consent With Deerfield Management Through December 4, 2015

GAITHERSBURG, Md., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the execution as of November 11, 2015 of a limited consent...
November 12, 2015 20:24 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Announces 3rd Quarter 2015 Financial Results

GAITHERSBURG, Md., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today reported financial results for the third quarter ended September 30,...
November 04, 2015 08:30 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics to Hold Third Quarter 2015 Conference Call on Friday, November 13 at 8:00 a.m. Eastern Time

GAITHERSBURG, Md., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics (OTCQX:NUOT), a pioneer in biodynamic therapies, announced today that it will report financial results for the third quarter of...
November 02, 2015 08:30 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Responds to Favorable CMS Hospital Outpatient Payment Final Ruling for Aurix System

GAITHERSBURG, Md., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the Aurix™ System reimbursement rate under the...
October 20, 2015 08:30 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Executes Amended Licensing Agreement With Arthrex

GAITHERSBURG, Md., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced it has executed an amended and restated license agreement...
September 14, 2015 08:30 ET | Source: Nuo Therapeutics, Inc.

Nuo Therapeutics Launches Educational Program to Support Wound Care Centers in Transition to ICD-10

First Webinar for Wound Care Professionals to be held September 15th at 1:00 p.m. Eastern on http://www.woundsresearch.com/ICD10 GAITHERSBURG, Md., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Nuo...